Summary: Low density lipoprotein (LDL), modified by chemical or biological means, was shown to induce macrophage cholesterol accumulation. The cholesterol and protein contents of LDL were decreased (by 10 and 15%, respectively) by incubation of the LDL for 2 h at 37 °C with normal washed platelet Suspension or with platelet-conditioned medium; these decreases were not affected by platelet activation. The plateletmodified LDL caused a greater increase (by up to 15%) in collagen-induced, in vitro platelet aggregation than control LDL. Incubation of mouse peritoneal macrophages with platelet-modified LDL for 18 h at 37 °C resulted in an elevation of the macrophage cholesterol ester content (by 35 -50%) s well s an increase in the cholesterol esterification rate (by 40 -70%), compared with the effect of control LDL. Macrophage cholesterol synthesis, however, was significantly decreased (by 40 -50%), compared with the effect of control LDL. The effect of LDL treated by platelet-conditioned medium was similar to that of platelet-modified LDL. The effect of platelet-modified LDL on macrophage cholesterol esterification was maximal within 24 h of incubation, and it was not significantly affected by Inhibition of cholesterol synthesis. The platelet-modified LDL was taken up by the macrophages in a saturable fashion and its uptake was competitively inhibited by LDL, but not by acetylated LDL. We conclude that platelet-modified LDL interacts with the LDL receptor and induces macrophage cholesterol accumulation. Since the modified lipoprotein induces in vitro foam cell fprmation and platelet activation, platelet-modified LDL could be considered to be pro-atherogenic.
Introduction
chqlesterol ester is hydrolysed to free cholesterol by Λ>Γ -u i * i' 14.·· · " acid lipase and then transferred to the cytoplasm. In Macrophage cholesterol accumulation is a prominent -; . ' , r , ,' ,. 4 ' ., . i T A . .. r ,, Λ t ' . Γ · ,"N the cytoplasm, the free cholesterol is estenfied by acyl early charactenstic of the atherosclerotic lesion (1 (4) . After Modified lipoprotein causes the accumulation of choreceptor-mediated endocytosis, the lipoprotein is lesterol ester in macrophages, thus leading to foam transferred to the lysosomal compartment, where the cell fonnation (l -3). Since platelets are involved in thc atherosclerotic proccss (5) and interact with plasma lipoproteins (6) , with the vessel wall and with macrophages (7), platelet-modified LDL, if formed in vivo, may be of importance in the pathogenesis of atherosclerosis. Recently we have shown that platelets can modify LDL composition in vitro (8) . The present study was undertaken in order to study the biological characteristics of platelet-modified LDL formed in vitro, in two distinct mechanisms involved in the atherogenic process: macrophage cholesterol accumulation and platelet activation.
removal by centrifugation at 1500g for 10 min. LDL (450 mg of protein per litre) was then added to thc platelet-conditioned medium and incubated for 2 h at 37 °C. Simiiarly, I25 I-labeIled LDL was prcparcd in the presence of 10 mg/1 I25 I-labelled LDL.
In some experimerits, platelet-conditioned medium was prepared from washed platelets activated by the addition of 5 · l O 3 units per litre thrombin fof the entire incubation period. The platelet-conditioned medium was treated with 5 · 1 3 units per litre hirudin to remove the thrombin.
. f
After incubation of platelet-conditioned medium with LDL, the LDL was reisolated äs described for the platelet-modified LDL System. Platelet-conditioned medium alone, incubated without LDL, was also studied for its effect on macrophage cholesterol metabolism.
Methods

Plalelet preparation
Venous blood was collected after a 14h fast from healthy subjects who had taken no medication for at least 3 weeks preceding the study. Blood was taken into acid citrate dextrose (2.5 g/l citric acid, 25 g/l sodium citrate, and 20 g/l dextrose) in a 6: l volume ratio. Platelet-rich plasma was prepared by low-speed centrifugation at 200 £ for 10 min at 23 °C. Washed platelets were prepared from the platelet-rich plasma. Acetic acid (10 mmol/1) was added to the platelet-rich plasma, which was then centrifuged at 1500g for 10 min. 
Lipoproteins
Blood was drawn into l g/l disodium EDTA. LDL was separated by discontinuous density gradient ultracentrifugation (9) and dialysed extensively against Hepes buffer in the presence of 0.3 mmol/1 EDTA. The purity of LDL was analysed by cellulose acetate electrophoresis and by Ouchterlony double immunodiffusion and immunoelectrophoresis.'Lipoprotein protein concentration was determined using the -Rad protein assay (10) (Bio-Rad Laboratories, Richmond, CA), and total and free cholesterol concentrations by the method of Chlamori & Henry (11) . LDL was acetylated by repeated addition of acetic anhydride/sodium acetate (12) . LDL iodination was performed by a modification of the iodine monochloride method (13) .
Incubation procedure LDL (650 mg of protein per litre) was incubated with or without washed platelets in Hepes buffer. A 4 ml platelel Suspension was used in a concentration of 10 I2 /1 and incubated for 2 h at 37 °C. At the end of the incubation period the platelets were removed by centrifugation at 1500g for 10 min, and LDL was reseparated from the supernatant by ultracentrifugation at a density of 1.210 kg/l. The appropriate control (LDL incubated without platelets) was also included. The lipoproteins were dialysed extensively against Hepes buffer containing 0.3 mmol/1 EDTA and analysed for protein and total, free and esterified cholesterol concentrations. The platelet pellet contained LDL äs determined by double immunodiffusion against anti-LDL. Upon incubation of 125 I-labelled LDL (10 mg/1) with washed platelets, 10-16% of the radioactivity was found to beplateletassociated.
Platelet-conditioned medium was prepared from washed platelets (their number equal to that used in platelet-modified LDL formation) and incubated for 2 h at 37 °C, followed by platelet
Platelet aggregation
The lipoproteins (control and platelet-modified LDL) were initially incubated with normal washed platelets (0.3 10 12 /1) for 30 min at 37 °C. Platelet aggregation, measured äs a percentage of maximal amplitude, was studied with collagen (l mg/1) äs aggregating agent (14) , using the appropriate cont rols without platelets, in a PAP-4 computerized aggregometer (Bio-Data Corporation, Hatboro, PA).
Mouse peritoneal macrophages
Cells were harvested from the peritoneal fluid of 10 female BALB/c mice (15-25 g) 4 days after intraperitoneal injection into each mouse of 3 ml 24 g/l thioglycolate in saline (15) . The cells (10-20 10 6 /mouse) were pooled, treated with 3 ml 8.3 g/l chloride, pH 7.4, and incubated for 5 min at 37 °C to remove red blood cell contamination. The cells were washed and centrifuged three times with phosphate-buiYered saline at 400 g for 10 min, then resuspended to 10 9 /1 in Dulbecco's modified Eagles medium containing horse serum (heat inactivated at 56 °C for 30 min, volume fraction 0.15), 100 kU/1 penicillin and 100 mg/1 streptomycin. The* cell Suspension was dispensed into 60 or 100 mm plastic Petri dishes and incubated in a hümidified 5% CO 2 incubator for 2h. The dishes were washed once with 5ml Dulbecco's modified Eagle's medium to remove nonadhefent cells, and the monolayer was then incubated under similar conditions for 18h. The medium was then changed to Dulbecco's modified Eagle's medium containing 2 g/l bovine serum albumin, either without any additions (control) or with the addition of the lipoproteins at various concentrations for 18 h.
At the end of the incubation period the cells were washed three times with phosphate buffered saline, then collected in 2^4 ml phosphate buffered saline using a rubber policeman and sedimented at 400 g for 10 min. The cell pellet was resuspended in 1.2 ml distilled water and sonicated twice for 20 s at 80 W. An aliquot of 0.1 ml was taken for protein determination, and lipids were extracted from the remainder with Chloroform/ methanol (2 -h l, by vol.). Total and free macrophage cholesterol (precipitated with digitonin), were then determined (11) . The cholesterol esterification rate in maerophages was measured äs the incorporation of pHJoleic acid into cellular cholesteryl [ l-labelled LDL by macrophagcs was studied s described elsewhere (12) .
Statistics
For each experiment, duplicate or triplicate parallel cultures were incubated. The Wilcoxon rank test was used to evaluate the significance of the results.
Results
Two hours after the incubation of washed platelets in Hepes buffer at 37 °C, a substantial loss (up to 20%), of platelet lipids and protein had occurred without changes in platelet aggregation ( fig. 1 ). The addition of bovine serum albumin or apyrase (which removed released ADP) did not significantly affect the loss of lipids and protein. Figure 2 demonstrates that various aggregating agents also had only little effect on the loss of platelet cholesterol and protein, except for arachidonic acid, which caused 43% greater release of total platelet cholesterol than in the control samples.
The lipid and protein losses were related to platelet concentration and were not affected by the presence of LDL in the medium ( fig. 3 ). From these studies (figs. l -3) we chose the appropriate incubation conditions for producing platelet-modified LDL.
When washed platelets (10 12 /1) were incubated with 650 mg/1 LDL for 2 h at 37 °C, followed by LDL Separation by recentrifugation, the platelet-modified LDL demonstrated a significant reduction of 15 -25% in LDL protein and cholesterol (free and esterified) content ( fig. 4 ). These changes resulted in a decreased ratio of free cholesterol to protein in the modified LDL, compared with the control LDL (incubated without platelets). Table l demonstrates that the change in LDL composition caused by plateletconditioned medium derived from normal washed platelets was similar to that caused by platelet suspension ( fig. 4 ). The absence of lactic dehydrogenase activity in the incubation medium suggests that the platelets did not release their cytoplasmic contents. Similarly, when platelet-conditioned medium was derived from thrombin-activated platelets (10 · l O 3 U/l, 2 h at 37 °C, and then thrombin removal by 10 -10 3 U/l hirudin), it caused a decrease in LDL cholesterol and protein from 1.56 ± 0.34 and l .10 ± 0.26 mmol/1 to 1.00 ± 0.27 and 1.01 ± 0.26 mmol/1, respectively. /1) were incubated in Hepes buffer for the indicated time at 37 °C, with no addition (o), with the addition of 3.5 g/l albumin (D), 100 mg/1 apyrase (Δ) or both (V). At the end of the incubation period, the platelets were removed by centrifugation at 1000g for 15 min, and the superaatant was used for analysis (mg/1) of protein, cholesterol, and phospholipids. Platelet aggregation induced by 5 μιηοΐ/ΐ ADP (o) or l mg/1 collagen (·) was studied with a separate platelet Suspension. Each point represents the mean of three separate results which differed by less then 4%. Similarly, LDL modified by platelet-conditioned medium also significantly increased normal washed platelet aggregation (tab. 2). Platelet-conditioned medium derived from thrombin activated platelets also modified LDL in a siniilar way. At a cholesterol concentration of 50 mg/1, LDL modified by plateletconditioned medium caused 93 + 8% aggregation, compared with 81 + 6% for control LDL.
When mouse peritoneal macrophages were incubated with platelet-modified LDL for 18h at 37 °C, the macrophage total cholesterol content was significantly elevated, compared with the effect of control LDL ( fig. 6 ). This cellular cholesterol elevation was due mainly to elevation of the cholesterol ester fraction. LDL modified by platelet-conditioned medium caused a similar elevation in macrophage cholesterol ester, but this was only 73% of the level achieved with platelet-modified LDL (fig. 6 ). The cholesterol esterification rate, measured s the amount of [ /dish) were incubated for 18h at 37 °C in Dulbecco's modified Eagle's medium containing 2 g/l bovine serum albumin and either LDL, platelet-modified LDL. or platelet-conditioned medium-treated LDL, using increasing lipoprotein concentrations. Macrophage total cholesterol (closed Symbols) and free cholesterol (open Symbols) content were then determined. Results represent mean ± SD of seven experiments (for total cholesterol P < 0.01 for plateletmodified LDL vs. control LDL).
modified LDL (flg. 7a); this was up to 70% more than the effect of control LDL. LDL and both modified LDLs, when incubated with macrophages for 18 h, caused a reduction in mouse peritoneal macrophage cholesterol synthesis, measured s [ 3 H]acetate incorporated into cellular cholesterol ( fig. 7b ). The decreases caused by both modified LDL however, were 50% and 28% greater than th f caused by control LDL. Similar results, although of lesser magnitude, were obtained when LDL modified by platelet conditioned medium was used instead of platelet-modified LDL ( fig. 7 a and 7b) . Table 3 demonstrates that plateletconditioned medium derived from thrombin-activated platelets caused the formation of a modified LDL, which had an effect on mouse peritoneal macrophage cholesterol metabolism similar to that of LDL modified by platelet-conditioned medium prepared from nonactivated platelets ( fig. 7) . When acetyl-LDL (50 mg/1) was incubated with macrophages for 18h at 37 °C, we fo nd a dramatic increase of 350% in the cellular cholesterol ester content and esterification, and a 60% decrease in cellular cholesterol synthesis, compared with controls containmg LDL. may not be detected by these gels). Platelet-conditioned medium contained two major protein bands corresponding to relative molecular masses of 60 000 and 100000. Platelet-modified LDL also inhibits the degradation of 125 I-labelled LDL modified by plateletconditioned medium by macrophages (data not shown). Following incubation of platelet-conditioned medium (25 mg protein per litre) with normal washed platelets (0.3 · 10 12 /1), Collagen (l mg/l)-induced platelet aggregation was reduced from 76 + 12% to 65 ± 8%; a similar effect was obtained with 50 g platelet-conditioned medium protein per litre (p < 0.01).
Platelet-conditioned medium alone (not interacting with LDL), when incubated with macrophages, increased the cellular cholesterol content and esterification, and reduced cellular cholesterol synthesis (tab. 4), in comparison with the control which contained no additions; these effects, however, were less than those caused by the lipoproteins (figs. 6, 7) . The addition of platelet-conditioned medium, together with control LDL or LDL modified by platelet-conditioned medium to the macrophages, results in an additive effect (tab. 5), implying separate mechanisms for cell cholesterol uptake induced by platelet-conditioned medium and by the lipoproteins. The lipids and proteins released from the platelet did not float up at a density of 1.210 kg/l, but remained in the infranatant.
Discussion
This study demonstrates that material released from platelets, can influence two different biochemical events. It can directly increase the macrophage cholesterol content and reduce in vitro platelet aggregation, and it can also modify LDL in such a way that the modified lipoprotein increases platelet aggregation and causes cholesterol accumulation in mouse peritoneal macrophages.
Although it could be suggested that the effect of LDL modified by plateletrconditioried medium on macrophage cholesterol metabolism is the r^sült of the action of a factor in platelet-conditioned medium (which may float together with the reisolated LDL), rather than associated with the lipoprotein, our data suggest two separate mechanisms for platelet-conditioned medium and LDL modified by platelet-conditioned medium.
We were able to show that the lipids and protein released from platelets did not float at a density of 1.210 kg/l and thus the platelet-conditioned medium lipids and protein could not be directly linked to the effect of the lipoproteins. Furthermore, when plateletconditioned medium was incubated with macrophages in the presence of control LDL or in the presence of LDL modified by platelet-conditioned medium the cholesterol content of the cells was in fact a restilt of an additive effect, implying that platelet-conditioned medium contributed to the macrophage cholesterol content independently of the contribution of LDL modified by platelet-conditioned medium. Plateletconditioned medium also displayed opposing effects to that of LDL modified by platelet-conditioned medium on in vitro platelet aggregation, suggesting again that LDL modified by platelet-conditioned medium Results are the mean of duplicates which varied by less than 2% (17) and also of a non-receptor interaction between LDL and macrophages. LDL modified by platelet-conditioned medium substantially increased the macrophage cholesterol content and esterification rate, and decreased cellular cholesterol synthesis, compared with control LDL. A similar pattern has been described for chemically and biologically modified LDL (18) (19) (20) . On the other hand endothelial-cell-modified LDL was formed only in the presence of the cells but not in the presence of the cell-conditioned medium (20) . However, unlike the other modified LDL preparations, LDL modified by platelet-conditioned medium reacts with the LDL receptor and not with the scavenger binding sites äs suggested from the competition experiments of 125 I-labelled LDL modified by platelet-conditioned medium with native LDL and acetyl LDL. The greater ability of LDL modified by platelet-conditioned medium to cause macrophage cholesterol aecumulation, compared with the effect of control LDL (even though they both bind to the same receptors) could be attributed to increased receptor uptake. This, in turn, may be due to the affinity of LDL modified by platelet-conditioned medium for the LDL receptors, compared with control LDL. Furthermore, the intracellular metabolism of cholesterol may differ, depending on whether it is derived from LDL pr from LDL modified by platelet-conditioned medium.
Activated platelets have been shown to release lipidprotein particles with platelet factor 3 like activity (21) , and it was also demonstrated recently that membrane microvesicles could be formed from platelets (22) . The lipids and protein which are lost from the platelets are very probäbly originated from the platelet gramiles and are released to the medium during incubation. The incubation itself could activate the platelets and this might be the reason that activation of platelets with various aggregating agents did not cause further modifications of the lipoprotein. We have demonstrated that lipids and protein released from platelets can affect lipoprptein composition (23) . It was also shown (7, 24) that platelet activation results in the release of lipids which in turn affect cholesterol accumulation in smooth muscle cells and in macrophages. Similarly, platelet-conditioned medium in our study was found to increase the macrophage cholesterol content.
No significant changes were found in the thiobarbituric acid reactive material expressed äs malondialdehyde concentrations, suggesting that LDL oxidation was not induced in LDL modified by platelet-conditioned medium formation and that LDL modified by platelet-conditioned medium is not malondialdehyde-LDL (19) . Some of the platelet material associated with LDL may include some aggregation-promoting substances released from the platelet granules, and this could account for the increased in vitro platelet aggregation. Platelets possess specific binding sites for LDL (6) , and the decrease of LDL constituents in LDL modified by platelet-conditioned medium could be related in part to LDL binding to a substance or substances released from the platelets. Thus, platelet-LDL interaction could result in removal of some subset of LDL, leaving a "hyperactive" subset beliind.
The materials released from the platelets and responsible for the modification of the LDL molecule are possibly platelet lipase, protease or lipid transferase. Alternatively, this platelet-released material might activate LDL-associated protease, phospholipase or other LDL-bound enzymes (25) .
The effect of platelet-modified LDL on macrophage cholesterol metabolism was similar to that already shown for other LDL preparations (26) ; LDL uptake by the cells results in lysosomal cholesterol ester hydrolysis, followed by reesterification and a parallel reduction in cell cholesterol synthesis. The Inhibition of cholesterol synthesis with mevinolin did not affect cell cholesterol esterification, suggesting that the cholesterol ester of LDL modified by platelet-conditioned medium itself (and not the cholesterol derived from biosynthesis) contributed to macrophage cholesterol accumulation.
Macrophage cholesterol accumulation and platelet activation represent parameters of atherogenicity (27) ; since LDL modified by platelet-conditioned medium affects both macrophages and platelets, it could therefore be regarded äs possessing atherogenic properties.
Platelets are found in abundance in the area of the atherosclerotic plaque; thus LDL modified by platelet-conditioned medium may be formed in vivo under certain pathological conditions and the platelet-modified LDL may then accelerate the atherosclerotic process.
